Related references
Note: Only part of the references are listed.Invasive serogroup B meningococci in England following three years of 4CMenB vaccination - First real-world data
Jay Lucidarme et al.
JOURNAL OF INFECTION (2022)
Vaccination of Infants with Meningococcal Group B Vaccine (4CMenB) in England
Shamez N. Ladhani et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Meningococcal B Vaccine and Meningococcal Carriage in Adolescents in Australia
Helen S. Marshall et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Effectiveness and Impact of the 4CMenB Vaccine against Group B Meningococcal Disease in Two Italian Regions Using Different Vaccination Schedules: A Five-Year Retrospective Observational Study (2014-2018)
Chiara Azzari et al.
VACCINES (2020)
Association of Use of a Meningococcus Group B Vaccine With Group B Invasive Meningococcal Disease Among Children in Portugal
Fernanda M. P. Rodrigues et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Multicomponent meningococcal serogroup B vaccination elicits cross-reactive immunity in infants against genetically diverse serogroup C, W and Y invasive disease isolates
Alessia Biolchi et al.
VACCINE (2020)
Genetic Meningococcal Antigen Typing System (gMATS): A genotyping tool that predicts 4CMenB strain coverage worldwide
Alessandro Muzzi et al.
VACCINE (2019)
Community outbreak of serogroup B invasive meningococcal disease in Beaujolais, France, February to June 2016: from alert to targeted vaccination
Alexandra Thabuis et al.
EUROSURVEILLANCE (2018)
Immunogenicity and safety of the multicomponent meningococcal B vaccine (4CMenB) in children and adolescents: a systematic review and meta-analysis
Maria Elena Flacco et al.
LANCET INFECTIOUS DISEASES (2018)
Reduced schedules of 4CMenB vaccine in infants and catch-up series in children: Immunogenicity and safety results from a randomised open-label phase 3b trial
Federico Martinon-Torres et al.
VACCINE (2017)
The epidemiology of invasive meningococcal disease in EU/EEA countries, 2004-2014
Robert Whittaker et al.
VACCINE (2017)
Impact of an Immunization Campaign to Control an Increased Incidence of Serogroup B Meningococcal Disease in One Region of Quebec, Canada
Philippe De Wals et al.
CLINICAL INFECTIOUS DISEASES (2017)
Effectiveness and impact of a reduced infant schedule of 4CMenB vaccine against group B meningococcal disease in England: a national observational cohort study
Sydel R. Parikh et al.
LANCET (2016)
Immunogenicity of a Meningococcal B Vaccine during a University Outbreak
Nicole E. Basta et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Predicted Strain Coverage of a New Meningococcal Multicomponent Vaccine (4CMenB) in Spain: Analysis of the Differences with Other European Countries
Raquel Abad et al.
PLOS ONE (2016)
Outbreak of Serogroup B Meningococcal Disease at a University - California, 2016
Hope H. Biswas et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2016)
Effectiveness of Meningococcal B Vaccine against Endemic Hypervirulent Neisseria meningitidis W Strain, England
Shamez N. Ladhani et al.
EMERGING INFECTIOUS DISEASES (2016)
First Use of a Serogroup B Meningococcal Vaccine in the US in Response to a University Outbreak
Lucy A. McNamara et al.
PEDIATRICS (2015)
Epidemiology of Infant Meningococcal Disease in the United States, 2006-2012
Jessica R. MacNeil et al.
PEDIATRICS (2015)
Calendario de vacunaciones de la Asociación Española de Pediatría (CAV-AEP): recomendaciones 2016
D. Moreno-Pérez et al.
ANALES DE PEDIATRIA (2015)
Persistence of bactericidal antibodies following early infant vaccination with a serogroup B meningococcal vaccine and immunogenicity of a preschool booster dose
Matthew D. Snape et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2013)
Immunogenicity and safety of an investigational multicomponent, recombinant, meningococcal serogroup B vaccine (4CMenB) administered concomitantly with routine infant and child vaccinations: results of two randomised trials
Timo Vesikari et al.
LANCET (2013)
Predicted strain coverage of a meningococcal multicomponent vaccine (4CMenB) in Europe: a qualitative and quantitative assessment
Ulrich Vogel et al.
LANCET INFECTIOUS DISEASES (2013)
Invasive meningococcal disease in England and Wales: Implications for the introduction of new vaccines
Shamez N. Ladhani et al.
VACCINE (2012)
Meningococcal Disease in Children in Merseyside, England: A 31 Year Descriptive Study
Michelle C. Stanton et al.
PLOS ONE (2011)
Influence of sequence variability on bactericidal activity sera induced by Factor H binding protein variant 1.1
Brunella Brunelli et al.
VACCINE (2011)
A universal vaccine for serogroup B meningococcus
Marzia M. Giuliani et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Share Paper
